1. Effect of the Glucagon-like Peptide-1 Mimetic on Ion- and Osmoregulating Renal Functions in Normoglycemia and Hyperglycemia
- Author
-
A. V. Kutina, T. A. Karavashkina, E. I. Shakhmatova, and E. V. Balbotkina
- Subjects
medicine.medical_specialty ,Physiology ,Chemistry ,Reabsorption ,Sodium ,medicine.medical_treatment ,05 social sciences ,Intraperitoneal injection ,Blood sugar ,Type 2 Diabetes Mellitus ,chemistry.chemical_element ,050105 experimental psychology ,Excretion ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Physiology (medical) ,Renal physiology ,Internal medicine ,medicine ,0501 psychology and cognitive sciences ,Exenatide ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Incretins are hormones with a wide range of biological activity. We studied the ratio of the glycemic effect of the glucagon-like peptide-1 mimetic and its effect on the renal excretion of sodium and water. It was found that both effects depend on the initial blood concentration of glucose. In normoglycemia, exenatide had no effect on blood sugar level, but it significantly increased urinary sodium excretion and reabsorption of solute-free water. In hyperglycemia the blood glucose concentration was normalized by exenatide, while the excretion of sodium by the kidneys and the reabsorption of solute-free water were increased to a small extent. This pattern was found both in patients with type 2 diabetes mellitus and in rats with hyperglycemia induced by intraperitoneal injection of glucose.
- Published
- 2019
- Full Text
- View/download PDF